You can’t fault Alcon AG’s focus. In the midst of an extended series of acquisitions, the company has a clear vision of ...

Researchers from the CUNY Advanced Science Research Center and their collaborators recently published a paper in Science ...

Sparks flew both ways Sept. 4 as Democratic senators pushed for Robert Kennedy to resign as secretary of the U.S. Department of Health and Human Services (HHS) during a Senate Finance Committee ...

Argenica Therapeutics Ltd. saw its stock drop 56% following mixed results for its ARG-007 phase II Seancon trial in acute ...

Several South Korean biotech and biopharmaceutical companies completed IND submissions or won nods to start clinical trials ...

Kardium Inc.’s Globe pulsed field system received U.S. FDA premarket approval, making it the fourth PFA system in the rapidly ...

Researchers at the University of California, Los Angeles and collaborators have analyzed what cell types are infected by ...

Jynneos, a current vaccine against orthopoxviruses such as smallpox and mpox virus, elicits only modest antibody responses, ...

Neucore Bio Inc. has received a $350,000 STTR phase I grant from the National Center for Advancing Translational Sciences ...

Arrowhead Pharmaceuticals Inc. has announced a global licensing and collaboration agreement with Novartis AG for ARO-SNCA, ...

The vaccine dominoes continue to fall in the U.S. This time one fell on the FDA’s Vaccines and Related Biological Products Advisory Committee, as one of Health and Human Services Secretary Robert ...

Vicentra BV’s insulin patch pump, Kaleido, will soon reach more patients with diabetes after it raised $85 million in a series D funding round. The company said the Kaleido is among the smallest, ...